Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Accelerate Diagnostics (AXDX) Insider Trading & Ownership

Accelerate Diagnostics logo

Accelerate Diagnostics (NASDAQ:AXDX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
43.60%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$314K
Number Of
Insiders Selling
(Last 3 Years)
3
Amount Of
Insider Selling
(Last 3 Years)
$168.66K
Get AXDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Accelerate Diagnostics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AXDX Insider Buying and Selling by Quarter

Accelerate Diagnostics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/4/2025Sell25,343$0.65$16,472.95  
4/4/2025
Larry Michael Mertz
CTO
Sell1,523$0.65$989.95  
4/1/2025
David Patience
CFO
Sell6,816$0.71$4,839.36  
2/26/2025
David Patience
CFO
Sell535$1.09$583.15  
12/3/2024
John Patience
Director
Buy200,000$1.57$314,000.00  
5/20/2024
Larry Michael Mertz
CTO
Sell361$0.88$317.68  
4/17/2024Sell26,735$0.78$20,853.30  
4/12/2024Sell26,545$0.86$22,828.70  
4/9/2024
David Patience
CFO
Sell13,296$0.87$11,567.52  
4/9/2024
Larry Michael Mertz
CTO
Sell13,984$0.87$12,166.08  
4/4/2024Sell15,887$0.88$13,980.56  
4/4/2024
Larry Michael Mertz
CTO
Sell978$0.88$860.64  
2/26/2024
David Patience
CFO
Sell350$0.96$336.00  
2/1/2024Sell494$1.30$642.20  
12/13/2023
David Patience
CFO
Sell97$4.39$425.83  
12/13/2023Sell739$4.39$3,244.21  
10/13/2023
David Patience
CFO
Sell96$5.83$559.68  
10/13/2023Sell734$5.83$4,279.22  
9/13/2023
David Patience
CFO
Sell96$6.53$626.88  
9/13/2023Sell733$6.53$4,786.49  
8/14/2023
David Patience
CFO
Sell95$6.80$646.00  
8/14/2023Sell751$6.80$5,106.80  
7/13/2023
David Patience
CFO
Sell92$6.90$634.80  
7/13/2023Sell729$6.90$5,030.10  
6/22/2023Sell2,726$7.10$19,354.60  
6/13/2023
David Patience
CFO
Sell128$9.00$1,152.00  
6/13/2023Sell839$9.00$7,551.00  
5/22/2023
Larry Michael Mertz
CTO
Sell348$7.20$2,505.60  
5/15/2023
David Patience
CFO
Sell122$6.90$841.80  
5/15/2023Sell794$6.90$5,478.60  
(Data available from 1/1/2013 forward)

AXDX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Accelerate Diagnostics includes David Patience, Jack Phillips, John Patience, and Larry Michael Mertz. Learn more on insiders at AXDX.

43.60% of Accelerate Diagnostics stock is owned by insiders. Learn more on AXDX's insider holdings.

The following insider purchased AXDX shares in the last 24 months: John Patience ($314,000.00).

Insiders have purchased a total of 200,000 AXDX shares in the last 24 months for a total of $314,000.00 bought.

The following insiders have sold AXDX shares in the last 24 months: David Patience ($5,422.51), Jack Phillips ($16,472.95), and Larry Michael Mertz ($1,307.63).

Insiders have sold a total of 34,578 Accelerate Diagnostics shares in the last 24 months for a total of $23,203.09 sold.



This page (NASDAQ:AXDX) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners